DMTKW DERMTECH INC C/WTS 29/08/2024(TO PUR COM)
- 0.002080
- 0.0000000.00%
DERMTECH INC C/WTS 29/08/2024(TO PUR COM) News
Express News | DermTech Shares Sink More Than 63% to $0.13 After Filing for Bankruptcy
Express News | DermTech Inc - on June 12 Entered Retention Agreements With Co's CEO Bret Christensen & Co's CFO Kevin Sun
Express News | DermTech Inc - Company's Reduction in Force Is Now Complete and One-Time Charge Will Be Incurred in Q2 of 2024
Express News | DermTech Inc - Intends to Continue Its Laboratory Operations and Processing Orders for DermTech Melanoma Test (Dmt)
Express News | DermTech to Sell Substantially All Assets
Express News | DermTech Inc: Rif Resulted in an Immediate Workforce Reduction of Approximately 15 Employees
Express News | DermTech - Company Also Implemented a Reduction in Force (Rif) to Significantly Reduce Expenses Associated With Its Current Operations to Preserve Cash
Express News | DermTech Inc - Also Implemented a Reduction in Force (Rif)
Express News | DermTech Files for Voluntary Chapter 11 Protection
Express News | DermTech Inc Lists Both Estimated Assets and Liabilities in Range of $50 Mln- $100 Mln- Court Filing
Express News | DermTech Inc Files for Chapter 11 Bankruptcy- Court Filing
10-Q: Q1 2024 Earnings Report
8-K: DERMTECH REPORTS FIRST-QUARTER 2024 FINANCIAL RESULTS
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
DermTech, Inc. (NASDAQ:DMTK) Analysts Are Cutting Their Estimates: Here's What You Need To Know
DermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call Transcript
Dermtech Inc C/Wts 29/08/2024(To Pur Com) | 8-K: DERMTECH REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
DermTech Announces Release Date for Fourth-quarter 2023 Financial Results
DermTech (NASDAQ:DMTK) Will Have To Spend Its Cash Wisely
No Data